Radiomics in Kidney Cancer: MR Imaging

Overview

Journal Magn Reson Imaging Clin N Am

Specialty Radiology

Date 2018 Nov 24

PMID 30466904

Citations 20

Authors

Alberto Diaz De Leon

Payal Kapur

Ivan Pedrosa

Affiliations

Soon will be listed here.

Abstract

Renal tumors encompass a heterogeneous disease spectrum, which confounds patient management and treatment. Percutaneous biopsy is limited by an inability to sample every part of the tumor. Radiomics may provide detail beyond what can be achieved from human interpretation. Understanding what new technologies offer will allow radiologists to play a greater role in caring for patients with renal cell carcinoma. In this article, we review the use of radiomics in renal cell carcinoma, in both the pretreatment assessment of renal masses and posttreatment evaluation of renal cell carcinoma, with special emphasis on the use of multiparametric MR imaging datasets.

Citing Articles

Development of the interpretable typing prediction model for osteosarcoma and chondrosarcoma based on machine learning and radiomics: a multicenter retrospective study.

Long Q, Wang F, Hu Y, Gao B, Zhang C, Ban B Front Med (Lausanne). 2024; 11:1497309.

PMID: 39635595 PMC: 11614641. DOI: 10.3389/fmed.2024.1497309.

Machine learning-based multiparametric MRI radiomics nomogram for predicting WHO/ISUP nuclear grading of clear cell renal cell carcinoma.

Yang Y, Zhang Z, Zhang H, Liu M, Zhang J Front Oncol. 2024; 14:1467775.

PMID: 39575426 PMC: 11578869. DOI: 10.3389/fonc.2024.1467775.

Artificial intelligence in fracture detection on radiographs: a literature review.

Lo Mastro A, Grassi E, Berritto D, Russo A, Reginelli A, Guerra E Jpn J Radiol. 2024; .

PMID: 39538068 DOI: 10.1007/s11604-024-01702-4.

The influence of manual segmentation strategies and different phases selection on machine learning-based computed tomography in renal tumors: a systematic review and meta-analysis.

Song H, Wang X, Wu R, Liu W Radiol Med. 2024; 129(7):1025-1037.

PMID: 38740709 DOI: 10.1007/s11547-024-01825-8.

The application of machine learning based on computed tomography images in the identification of renal tumors in children.

Song H, Wang X, Wang H, Guo F, Wu R, Liu W Transl Pediatr. 2024; 13(3):417-426.

PMID: 38590367 PMC: 10998986. DOI: 10.21037/tp-23-508.

References

Drevs J, Muller-Driver R, Wittig C, Fuxius S, Esser N, Hugenschmidt H . PTK787/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging. Cancer Res. 2002; 62(14):4015-22. View

Zhang J, Pedrosa I, Rofsky N . MR techniques for renal imaging. Radiol Clin North Am. 2003; 41(5):877-907. DOI: 10.1016/s0033-8389(03)00069-1. View

Reeder S, McKenzie C, Pineda A, Yu H, Shimakawa A, Brau A . Water-fat separation with IDEAL gradient-echo imaging. J Magn Reson Imaging. 2007; 25(3):644-52. DOI: 10.1002/jmri.20831. View

Mertz K, Demichelis F, Kim R, Schraml P, Storz M, Diener P . Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer. Hum Pathol. 2007; 38(10):1454-62. DOI: 10.1016/j.humpath.2007.05.017. View

Noguchi T, Yoshiura T, Hiwatashi A, Togao O, Yamashita K, Nagao E . Perfusion imaging of brain tumors using arterial spin-labeling: correlation with histopathologic vascular density. AJNR Am J Neuroradiol. 2008; 29(4):688-93. PMC: 7978189. DOI: 10.3174/ajnr.A0903. View

Flaherty K, Rosen M, Heitjan D, Gallagher M, Schwartz B, Schnall M . Pilot study of DCE-MRI to predict progression-free survival with sorafenib therapy in renal cell carcinoma. Cancer Biol Ther. 2008; 7(4):496-501. DOI: 10.4161/cbt.7.4.5624. View

Horiguchi A, Asano T, Asano T, Ito K, Sumitomo M, Hayakawa M . Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma. J Urol. 2008; 180(3):1137-40. DOI: 10.1016/j.juro.2008.04.135. View

de Bazelaire C, Alsop D, George D, Pedrosa I, Wang Y, Michaelson M . Magnetic resonance imaging-measured blood flow change after antiangiogenic therapy with PTK787/ZK 222584 correlates with clinical outcome in metastatic renal cell carcinoma. Clin Cancer Res. 2008; 14(17):5548-54. DOI: 10.1158/1078-0432.CCR-08-0417. View

Sun M, Ngo L, Genega E, Atkins M, Finn M, Rofsky N . Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings. Radiology. 2009; 250(3):793-802. DOI: 10.1148/radiol.2503080995. View

10.

Taouli B, Thakur R, Mannelli L, Babb J, Kim S, Hecht E . Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. Radiology. 2009; 251(2):398-407. DOI: 10.1148/radiol.2512080880. View

11.

Pedrosa I, Alsop D, Rofsky N . Magnetic resonance imaging as a biomarker in renal cell carcinoma. Cancer. 2009; 115(10 Suppl):2334-45. DOI: 10.1002/cncr.24237. View

12.

Schor-Bardach R, Alsop D, Pedrosa I, Solazzo S, Wang X, Marquis R . Does arterial spin-labeling MR imaging-measured tumor perfusion correlate with renal cell cancer response to antiangiogenic therapy in a mouse model?. Radiology. 2009; 251(3):731-42. PMC: 2687534. DOI: 10.1148/radiol.2521081059. View

13.

Weikert S, Ljungberg B . Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention. World J Urol. 2010; 28(3):247-52. DOI: 10.1007/s00345-010-0555-1. View

14.

Wang H, Cheng L, Zhang X, Wang D, Guo A, Gao Y . Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T. Radiology. 2010; 257(1):135-43. DOI: 10.1148/radiol.10092396. View

15.

Rosenkrantz A, Niver B, Fitzgerald E, Babb J, Chandarana H, Melamed J . Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade. AJR Am J Roentgenol. 2010; 195(5):W344-51. DOI: 10.2214/AJR.10.4688. View

16.

Buckler A, Bresolin L, Reed Dunnick N, Sullivan D . A collaborative enterprise for multi-stakeholder participation in the advancement of quantitative imaging. Radiology. 2011; 258(3):906-14. DOI: 10.1148/radiol.10100799. View

17.

Yang X, Knopp M . Quantifying tumor vascular heterogeneity with dynamic contrast-enhanced magnetic resonance imaging: a review. J Biomed Biotechnol. 2011; 2011:732848. PMC: 3085501. DOI: 10.1155/2011/732848. View

18.

Goh V, Ganeshan B, Nathan P, Juttla J, Vinayan A, Miles K . Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker. Radiology. 2011; 261(1):165-71. DOI: 10.1148/radiol.11110264. View

19.

Iakovlev V, Gabril M, Dubinski W, Scorilas A, Youssef Y, Faragalla H . Microvascular density as an independent predictor of clinical outcome in renal cell carcinoma: an automated image analysis study. Lab Invest. 2011; 92(1):46-56. DOI: 10.1038/labinvest.2011.153. View

20.

Sasiwimonphan K, Takahashi N, Leibovich B, Carter R, Atwell T, Kawashima A . Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging. Radiology. 2012; 263(1):160-8. DOI: 10.1148/radiol.12111205. View